Costs of adjuvant breast cancer treatments.
Oestreicher
Nina
N
University of California, San Francisco, CA, USA. hill.nina@gene.com
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000191:economics; D005260:Female; D017048:Health Care Costs; D006801:Humans; D000077341:Lapatinib; D011799:Quinazolines / Q000191:economics / Q000627:therapeutic use; D013629:Tamoxifen / Q000191:economics / Q000627:therapeutic use; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011799:Quinazolines; D013629:Tamoxifen; D000077341:Lapatinib; D000068878:Trastuzumab